NEA Management Company as of June 30, 2020
Portfolio Holdings for NEA Management Company
NEA Management Company holds 46 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Sprout Social Com Cl A (SPT) | 9.8 | $244M | 9.0M | 27.00 | |
| Mersana Therapeutics (MRSN) | 7.5 | $186M | 8.0M | 23.40 | |
| Oyster Point Pharma | 6.9 | $171M | 5.9M | 28.88 | |
| Adaptimmune Therapeutics Adr (ADAP) | 6.9 | $171M | 17M | 10.01 | |
| Allakos (ALLK) | 6.6 | $163M | 2.3M | 71.86 | |
| Crispr Therapeutics Namen Akt (CRSP) | 6.2 | $154M | 2.1M | 73.49 | |
| Cloudflare Cl A Com (NET) | 5.9 | $146M | 4.1M | 35.95 | |
| Black Diamond Therapeutics (BDTX) | 5.8 | $145M | 3.4M | 42.16 | |
| Imara | 4.5 | $111M | 4.0M | 27.63 | |
| Rhythm Pharmaceuticals (RYTM) | 4.4 | $110M | 4.9M | 22.30 | |
| Akouos | 3.9 | $97M | 4.3M | 22.50 | |
| Ardelyx (ARDX) | 3.8 | $94M | 14M | 6.92 | |
| Aurinia Pharmaceuticals (AUPH) | 3.4 | $84M | 5.2M | 16.25 | |
| Mirum Pharmaceuticals (MIRM) | 3.3 | $82M | 4.2M | 19.46 | |
| Casper Sleep | 2.2 | $56M | 6.2M | 8.97 | |
| Trillium Therapeutics Com New | 1.9 | $46M | 5.7M | 8.09 | |
| Trevi Therapeutics (TRVI) | 1.6 | $39M | 5.9M | 6.58 | |
| Mei Pharma Com New | 1.4 | $35M | 8.5M | 4.13 | |
| Glycomimetics (GLYC) | 1.4 | $34M | 9.1M | 3.76 | |
| Galera Therapeutics (GRTX) | 1.3 | $31M | 4.4M | 7.14 | |
| Phasebio Pharmaceuticals (PHASQ) | 1.2 | $31M | 6.6M | 4.60 | |
| Affimed Therapeutics B V | 1.1 | $28M | 6.1M | 4.62 | |
| Obseva Sa | 1.1 | $27M | 4.6M | 5.89 | |
| Liquidia Technologies (LQDA) | 0.8 | $21M | 2.5M | 8.42 | |
| Aveo Pharmaceuticals | 0.8 | $20M | 4.0M | 5.15 | |
| Genocea Biosciences (GNCAQ) | 0.7 | $17M | 7.2M | 2.30 | |
| Champions Oncology Com New (CSBR) | 0.7 | $16M | 1.7M | 9.56 | |
| Strongbridge Biopharma Shs Usd | 0.6 | $16M | 4.1M | 3.78 | |
| Bloom Energy Corp Com Cl A (BE) | 0.6 | $15M | 1.3M | 10.88 | |
| Xenon Pharmaceuticals (XENE) | 0.5 | $12M | 992k | 12.54 | |
| Marker Therapeutics Ord | 0.4 | $10M | 5.0M | 2.07 | |
| Lumos Pharma (LUMO) | 0.3 | $8.7M | 527k | 16.49 | |
| Synlogic | 0.3 | $8.6M | 4.2M | 2.03 | |
| Dasan Zhone Solutions Com New | 0.3 | $8.5M | 956k | 8.93 | |
| Cti Biopharma Corp Com New | 0.3 | $8.3M | 7.1M | 1.16 | |
| Senseonics Hldgs (SENS) | 0.3 | $6.2M | 16M | 0.39 | |
| Rigel Pharmaceuticals Com New (RIGL) | 0.2 | $5.9M | 3.2M | 1.83 | |
| Erytech Pharma Sa Adr | 0.2 | $5.7M | 625k | 9.15 | |
| Trevena | 0.2 | $5.7M | 3.8M | 1.50 | |
| Verona Pharma Ads (VRNA) | 0.2 | $5.7M | 1.2M | 4.68 | |
| Lexicon Pharmaceuticals Com New (LXRX) | 0.2 | $4.8M | 2.4M | 2.00 | |
| Millendo Therapeutics | 0.1 | $3.1M | 1.8M | 1.76 | |
| Regulus Therapeutics Com New | 0.1 | $1.4M | 2.1M | 0.68 | |
| Akari Therapeutics Adr | 0.0 | $986k | 452k | 2.18 | |
| Tracon Pharmaceuticals (TCON) | 0.0 | $680k | 347k | 1.96 | |
| Sunesis Pharmaceuticals Com Par | 0.0 | $342k | 1.3M | 0.26 |
